vs
南玻集团（CSGS）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
南玻集团的季度营收约是Bio-Techne的1.1倍（$323.1M vs $295.9M），Bio-Techne净利率更高（12.8% vs 2.2%，领先10.7%），南玻集团同比增速更快（2.0% vs -6.4%），过去两年南玻集团的营收复合增速更高（4.6% vs 4.2%）
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商，业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售，产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
CSGS vs TECH — 直观对比
营收规模更大
CSGS
是对方的1.1倍
$295.9M
营收增速更快
CSGS
高出8.5%
-6.4%
净利率更高
TECH
高出10.7%
2.2%
两年增速更快
CSGS
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $323.1M | $295.9M |
| 净利润 | $7.0M | $38.0M |
| 毛利率 | 50.0% | 64.6% |
| 营业利润率 | 9.0% | 18.4% |
| 净利率 | 2.2% | 12.8% |
| 营收同比 | 2.0% | -6.4% |
| 净利润同比 | -79.7% | 68.3% |
| 每股收益（稀释后） | $0.24 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGSTECH
| Q4 25 | $323.1M | $295.9M | ||
| Q3 25 | $303.6M | — | ||
| Q2 25 | $297.1M | $317.0M | ||
| Q1 25 | $299.5M | $316.2M | ||
| Q4 24 | $316.7M | $297.0M | ||
| Q3 24 | $295.1M | $289.5M | ||
| Q2 24 | $290.3M | $306.1M | ||
| Q1 24 | $295.1M | $303.4M |
净利润CSGSTECH
| Q4 25 | $7.0M | $38.0M | ||
| Q3 25 | $20.5M | — | ||
| Q2 25 | $12.3M | $-17.7M | ||
| Q1 25 | $16.1M | $22.6M | ||
| Q4 24 | $34.5M | $34.9M | ||
| Q3 24 | $19.1M | $33.6M | ||
| Q2 24 | $13.8M | $40.6M | ||
| Q1 24 | $19.5M | $49.1M |
毛利率CSGSTECH
| Q4 25 | 50.0% | 64.6% | ||
| Q3 25 | 48.1% | — | ||
| Q2 25 | 49.5% | 62.7% | ||
| Q1 25 | 48.4% | 67.9% | ||
| Q4 24 | 51.3% | 65.3% | ||
| Q3 24 | 49.4% | 63.2% | ||
| Q2 24 | 47.3% | 66.4% | ||
| Q1 24 | 46.5% | 67.4% |
营业利润率CSGSTECH
| Q4 25 | 9.0% | 18.4% | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 10.0% | -7.5% | ||
| Q1 25 | 9.8% | 12.2% | ||
| Q4 24 | 13.4% | 16.0% | ||
| Q3 24 | 10.8% | 13.8% | ||
| Q2 24 | 8.8% | 15.0% | ||
| Q1 24 | 10.8% | 22.1% |
净利率CSGSTECH
| Q4 25 | 2.2% | 12.8% | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 4.1% | -5.6% | ||
| Q1 25 | 5.4% | 7.1% | ||
| Q4 24 | 10.9% | 11.7% | ||
| Q3 24 | 6.5% | 11.6% | ||
| Q2 24 | 4.8% | 13.3% | ||
| Q1 24 | 6.6% | 16.2% |
每股收益（稀释后）CSGSTECH
| Q4 25 | $0.24 | $0.24 | ||
| Q3 25 | $0.73 | — | ||
| Q2 25 | $0.44 | $-0.11 | ||
| Q1 25 | $0.57 | $0.14 | ||
| Q4 24 | $1.20 | $0.22 | ||
| Q3 24 | $0.67 | $0.21 | ||
| Q2 24 | $0.48 | $0.26 | ||
| Q1 24 | $0.68 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.0M | $172.9M |
| 总债务越低越好 | $539.5M | $260.0M |
| 股东权益账面价值 | $283.7M | $2.0B |
| 总资产 | $1.5B | $2.5B |
| 负债/权益比越低杠杆越低 | 1.90× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CSGSTECH
| Q4 25 | $180.0M | $172.9M | ||
| Q3 25 | $158.4M | — | ||
| Q2 25 | $145.9M | $162.2M | ||
| Q1 25 | $136.0M | $140.7M | ||
| Q4 24 | $161.8M | $177.5M | ||
| Q3 24 | $118.4M | $187.5M | ||
| Q2 24 | $110.4M | $152.9M | ||
| Q1 24 | $120.8M | $145.3M |
总债务CSGSTECH
| Q4 25 | $539.5M | $260.0M | ||
| Q3 25 | $538.6M | — | ||
| Q2 25 | $537.8M | $346.0M | ||
| Q1 25 | $537.6M | $330.0M | ||
| Q4 24 | $538.5M | $300.0M | ||
| Q3 24 | $539.5M | $300.0M | ||
| Q2 24 | $540.5M | $319.0M | ||
| Q1 24 | $541.5M | $389.0M |
股东权益CSGSTECH
| Q4 25 | $283.7M | $2.0B | ||
| Q3 25 | $289.5M | — | ||
| Q2 25 | $290.7M | $1.9B | ||
| Q1 25 | $283.1M | $2.0B | ||
| Q4 24 | $282.6M | $2.1B | ||
| Q3 24 | $288.4M | $2.1B | ||
| Q2 24 | $273.3M | $2.1B | ||
| Q1 24 | $269.3M | $2.0B |
总资产CSGSTECH
| Q4 25 | $1.5B | $2.5B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | $1.5B | $2.7B | ||
| Q3 24 | $1.4B | $2.7B | ||
| Q2 24 | $1.4B | $2.7B | ||
| Q1 24 | $1.3B | $2.7B |
负债/权益比CSGSTECH
| Q4 25 | 1.90× | 0.13× | ||
| Q3 25 | 1.86× | — | ||
| Q2 25 | 1.85× | 0.18× | ||
| Q1 25 | 1.90× | 0.16× | ||
| Q4 24 | 1.91× | 0.14× | ||
| Q3 24 | 1.87× | 0.14× | ||
| Q2 24 | 1.98× | 0.15× | ||
| Q1 24 | 2.01× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.2M | — |
| 自由现金流经营现金流 - 资本支出 | $55.8M | — |
| 自由现金流率自由现金流/营收 | 17.3% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 8.46× | — |
| 过去12个月自由现金流最近4个季度 | $141.4M | — |
8季度趋势，按日历期对齐
经营现金流CSGSTECH
| Q4 25 | $59.2M | — | ||
| Q3 25 | $47.9M | — | ||
| Q2 25 | $37.3M | $98.2M | ||
| Q1 25 | $11.5M | $41.1M | ||
| Q4 24 | $82.5M | $84.3M | ||
| Q3 24 | $39.5M | $63.9M | ||
| Q2 24 | $43.1M | $75.5M | ||
| Q1 24 | $-29.4M | $81.0M |
自由现金流CSGSTECH
| Q4 25 | $55.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $34.6M | $93.3M | ||
| Q1 25 | $7.1M | $31.0M | ||
| Q4 24 | $76.6M | $77.5M | ||
| Q3 24 | $32.0M | $54.7M | ||
| Q2 24 | $38.8M | $57.5M | ||
| Q1 24 | $-34.1M | $64.5M |
自由现金流率CSGSTECH
| Q4 25 | 17.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 11.6% | 29.4% | ||
| Q1 25 | 2.4% | 9.8% | ||
| Q4 24 | 24.2% | 26.1% | ||
| Q3 24 | 10.8% | 18.9% | ||
| Q2 24 | 13.4% | 18.8% | ||
| Q1 24 | -11.6% | 21.3% |
资本支出强度CSGSTECH
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 1.5% | 3.2% | ||
| Q4 24 | 1.9% | 2.3% | ||
| Q3 24 | 2.5% | 3.2% | ||
| Q2 24 | 1.5% | 5.9% | ||
| Q1 24 | 1.6% | 5.4% |
现金转化率CSGSTECH
| Q4 25 | 8.46× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 3.04× | — | ||
| Q1 25 | 0.71× | 1.82× | ||
| Q4 24 | 2.39× | 2.42× | ||
| Q3 24 | 2.07× | 1.90× | ||
| Q2 24 | 3.12× | 1.86× | ||
| Q1 24 | -1.51× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
